---
title: "NP47924 Cytokine Modulators"
ocid: "ocds-r6ebe6-0000781799"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000781799"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000781799.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000781799.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)"
published: "2025-03-19"
---

# NP47924 Cytokine Modulators

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)  
Current stage: Award  
OCID: ocds-r6ebe6-0000781799

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000781799)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000781799.json)

## Summary

The Common Services Agency, more widely known as NHS National Services Scotland (NSS), has completed the public procurement process for the supply of Cytokine Modulators. This tender falls within the health industry category and covers all entities under the National Health Service (Scotland) Act 1978, incorporating any Integrated Joint Boards from the Public Bodies (Joint Working) Scotland Act 2014. Located primarily in the UK region of Scotland (UKM), the process moved to the Award stage as of 19th March 2025, following completion of the tender period that ended on 2nd December 2024. The procurement method used was an open procedure, focusing on procuring goods through multiple frameworks with specific lots such as Etanercept, Infliximab IV and SC, and various concentrations of Methotrexate pens and syringes.

This procurement presents significant business growth opportunities for large pharmaceutical companies providing Cytokine Modulators, with awarded contracts including Biogen Idec Ltd, Sandoz, Pfizer Ltd, and others. Due to the large scale and structured nature of this framework agreement, companies that have robust manufacturing capabilities, valid UK Marketing Authorisations, and compliance with MHRA best practices are well-suited to compete. The framework also encourages involvement with the NHS Scotland's Community Benefits Gateway, aiding in delivering community benefits within Scotland, promoting corporate social responsibility alongside economic opportunities.

## Notice

Supply of Cytokine Modulators to NHS Scotland.

### Lot Information

Etanercept

Supply of Etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Infliximab IV

Supply of Infliximab IV to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of five (5) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Infliximab SC

Supply of Infliximab SC to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate syringes (25mg/1 ml concentration)

Supply of Methotrexate syringes (25mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate pens (25mg/1ml concentration)

Supply of Methotrexate pens (25mg/1ml concentration)to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate pens (50mg/1 ml concentration)

Supply of Methotrexate pens (50mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate syringes (50mg/1ml concentration)

Supply of Methotrexate syringes (50mg/1ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR526310 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 19 Mar 2025 |
| Submission deadline | 2 Dec 2024 |
| Future notice date | Not specified |
| Award date | 29 Jan 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | £22,963,164 |
| Awards value | Not specified |
| Contracts value | £55,943,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 8 |
| Supplier names | ACCORD HEALTHCARE; BIOGEN IDEC; CELLTRION HEALTHCARE UNITED KINGDOM; JANSSEN CILAG; MEDAC PHARMA; NORDIC PHARMA; PFIZER; SANDOZ |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 19 Mar 2025 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR526310
- 1 Nov 2024 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV517389

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV517389
  NP47924 Cytokine Modulators - Supply of Cytokine Modulators to NHS Scotland.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR526310
  NP47924 Cytokine Modulators - Supply of Cytokine Modulators to NHS Scotland.

## Notice URLs

- http://
- http://www.nss.nhs.scot/browse/procurement-and-logistics
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000781799
- https://scotcourts.gov.uk/the-courts/sheriff-court/about-sheriff-courts
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000781799. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000781799.json.